Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
https://business.uoregon.edu/centers/lce
Clinical Trials
Related News
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Phase 1
Completed
Conditions
Anxiety
Interventions
Drug: Psilocybin (drug)
Other: Niacin
Diagnostic Test: MRI
Subscribe
First Posted Date
2006-03-14
Last Posted Date
2024-03-20
Lead Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Target Recruit Count
12
Registration Number
NCT00302744
Locations
🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
Subscribe
Ventricular Size and Value Calcification Measures by Computed Tomography - Ancillary to MESA
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Atherosclerosis
Coronary Arteriosclerosis
Subscribe
First Posted Date
2003-08-04
Last Posted Date
2013-10-28
Lead Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Target Recruit Count
6814
Registration Number
NCT00065780
Subscribe
Prev
1
4
5
6
7
8
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy